GLP-1

A woman holding a GLP-1 weight loss drug as manufacturers developing next-generation obesity and weight loss medicines.
The race to build the next generation of weight loss drugs

The obesity drug market is entering a new phase as pharmaceutical companies race to develop oral therapies, combination treatments and next-generation medicines. With forecasts pointing to a $100 billion annual market, competition is shifting from two dominant players to a much broader field of innovators.

Amazon Pharmacy delivery vehicle dispersing GLP-1 medication prescriptions.
Amazon’s healthcare strategy now includes same-day Ozempic

Amazon Pharmacy is expanding access to oral GLP-1 medications through same-day delivery and prescription kiosks inside One Medical clinics, signaling a broader shift toward logistics-driven healthcare delivery.